ESR1 and breast cancer: Several independent groups have undertaken RNA profile analysis of primary human breast cancers and mouse models of PIK3CA mutant ER+ breast cancer and uncovered AKT-independent downstream signaling events that contribute to tumor progression [25,96,99].